SCHEMBL29614843

SCHEMBL29614843

CC(C)c1cccc(NCCC(=O)O)c1-n1c(=O)[nH]c(=O)c2cc(F)c(-c3c(N)cccc3F)nc21

nearest known ligand 0.43

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
KRAS P01116 20/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29614782 0.93 KRAS (0.43) KRAS
SCHEMBL22848359 0.93 KRAS (0.43) KRAS
SCHEMBL29614823 0.88 KRAS (0.42) KRAS
SCHEMBL24436331 0.88 KRAS (0.43) KRAS
SCHEMBL24436596 0.85 ITGB2 (0.32) KRAS
SCHEMBL29614826 0.85 ITGB2 (0.32) KRAS
SCHEMBL24436730 0.80 KRAS (0.42) KRAS
SCHEMBL24436453 0.79 KRAS (0.48) KRAS
SCHEMBL29614983 0.79 KRAS (0.48) KRAS
SCHEMBL29614834 0.77 PARP1 (0.36) KRAS

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3990448-A1 HETEROCYCLIC COMPOUNDS AS INHIBITORS OF KRAS G12C Guangdong Newopp Biopharmaceuticals Co., Ltd. (CN) 2022-05-04 EP disclosed